MUSTANG BIO, INC. (MBIO) Free cash flow 2017–2024
MUSTANG BIO, INC. (MBIO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$11.4MFY2024 · since FY2017: -$13.4M → -$11.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$11.4M | +77.0% |
| FY2023 | -$49.5M | +26.9% |
| FY2022 | -$67.8M | -17.6% |
| FY2021 | -$57.7M | -46.9% |
| FY2020 | -$39.2M | -9.2% |
| FY2019 | -$35.9M | -37.6% |
| FY2018 | -$26.1M | -95.3% |
| FY2017 | -$13.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More MBIO financial trends
MBIO RevenueMBIO Net incomeMBIO Net marginMBIO Gross profitMBIO Gross marginMBIO Operating incomeMBIO Operating marginMBIO Operating cash flowMBIO Capital expendituresMBIO Return on equityMBIO Stock buybacksMBIO Dividends paidMBIO Total assetsMBIO Total liabilitiesMBIO Shareholders’ equityMBIO overview →